Cargando…
Abstract 7: Use of growth hormone therapy in short patients born small for gestational age: Data from real-life French clinical practice
Background: A national French registry was created to address the absence of data on final height and safety following long-term exposure to supraphysiological doses of growth hormone (GH) in children born small for gestational age (SGA). Methods: This observational, non-interventional study (NCT015...
Autores principales: | Paulose, Rinz, Coutant1, Régis, Leheup2, Bruno, Nicolino3, Marc, Salles4, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067864/ http://dx.doi.org/10.4103/2230-8210.342308 |
Ejemplares similares
-
Abstract 2: Effectiveness and safety of early growth hormone treatment in children born small for gestational age: Long-term data from NordiNet® International Outcome Study (IOS) and ANSWER program
por: Ranjan, K M, et al.
Publicado: (2022) -
Abstract 92: Contemporaneous association of pheochromocytoma with Cushing's syndrome
por: Acharya, Himamshu, et al.
Publicado: (2022) -
Abstract 1: Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis
por: Dutta, Deep, et al.
Publicado: (2022) -
Abstract 17: Spontaneous hypoglycaemia due to insulin autoimmune syndrome in five cases, response to steroid therapy and rituximab
por: Batra, C M, et al.
Publicado: (2022) -
Abstract 58: Favourable outcomes with therapeutic glucocorticoid regimen compared to replacement glucocorticoid regimen in primary hypophysitis
por: Das, Liza, et al.
Publicado: (2022)